FY2022-24 Memorandum of Agreement with the State of Alaska Department of Health and Social ServicesTHE STATE
OIALASKA
Department of
Health and Social Services
i%I ANAs E[. ILL
GOVFK�AM MfKF DUNLEA.VY — —
Memorandum of Agreement Between
State of Alaska - Department of Health and Social Services
Division of Public Health — COVID-19 Emergency Operations Center (DPH-EOC)
- and —
Kodiak island Borough (KIB)
C0621 -570 -EE
PURPOSE AND SCOPE
The purpose of this MOA is to provide funding to government entities to implement
community -driven strategies that support COVID-19 related activities. These activities
include improving efforts and increase access to COVID-19 testing in the community,
building capacity to increase access to COVID-19 vaccine in the community, and
implementing strategies that decrease health inequities, as well as other COVID-19 related
recovery and prevention strategies.
11. THE DPH AGREES TO:
Provide support to the community on COVID-19 vaccine administration, testing, and
other COVID-19 related activities. The COVID-19 EOC Team is available to consult and provide
technical assistance to government entities and to pre -approved pass-through recipients of
award funding. The team will also ensure that approved activities meet the funding
requirements.
III. THE KIB AGREES TO:
Support expanded COVID-19 testing capacity and vaccine administration, the purchase
of COVID-19 related supplies, and COVID-19 testing and vaccine communication and education
efforts with pass-through funding to Kodiak Area Native Association and
Kodiak Community Health Center.
Recipient must establish/maintain/provide electronic reporting of SARS-CoV2/COVID-
191aboratory data to CDC daily per the guidance provided by CDC (e.g., CELR). This
includes all testing (e.g., positive/negative, PCR, Point -of -Care, etc.) and complete data
elements (e.g., race/ethnicity).
Any additional activities not specifically stated in this MOA must be approved by the
COVID-19 EOC Team prior to those activities occurring.
IV. JOINT RESPONSIBILITIES:
Both parties will make a good faith effort to communicate about any issues that might arise that
will impact the timeliness of activities, reporting, or payment.
V. PERIOD OF AGREEMENT ANDTERMINATION:
This agreement will terminate on March 31, 2022 and receipts must be for activities
prior to this date. Funds are intended to be used to support staff time (including
overtime), supplies, and other materials as needed to support COVID-19 related
activities.
VI. TERMS OF PAYMENT
The State agrees to pay the KIB up to $513,946.72 over the term of this agreement.
The Recipient will submit monthly invoices detailing services performed in
accordance with APPENDIX A (provided separately).
The invoice must:
• reference the recipient's name, address and phone number
• reference the contract number: C0621 -570 -EE
• include an invoice number
• Reference the Alaska Division of Public Health - COVID-19 EOC Team
Failure to include the required information on invoices may cause an unavoidable
delay to the payment process. The State will pay all invoices within thirty (30) days
of invoice approval by the Project Director. The Recipient shall submit final invoices
to the address specified below no later than 30 days after March 31, 2022.
Email invoices to:
covidadmin0alaska.gov
(please reference Community MOA Reimbursement Request in the subject line)
Notwithstanding any other provision of this contract, it is understood and agreed
that The State shall withhold reimbursement at any time the recipient fails to comply
with the terms of the MOA.
VII. GRANT COMPLIANCE FROM THE FEDERAL NOTICE OF GRANT AWARD
CFDA Number 93.323, U.S. Department of Health and Human Services, Epidemiology and Laboratory
Capacity for Infection and Control of Emerging Infections Diseases
Recipients must comply with the Terms and Conditions of this award and all Code of Federal Regulations.
Coronavirus Disease 2019 (COVID-19) Funds: A recipient of a grant or cooperative agreement awarded by
the Department of Health and Human Services (HHS) agrees, as applicable to the award, to: 1) comply with
existing and/or future directives and guidance from the Secretary regarding control of the spread of
COVID-19; 2) in consultation and coordination with HHS, provide, commensurate with the condition of the
individual, COVID-19 patient care regardless of the individual's home jurisdiction and/or appropriate
public health measures (e.g., social distancing, home isolation); and 3) assist the United States Government
in the implementation and enforcement of federal orders related to quarantine and isolation.
• To achieve the public health objectives of ensuring the health, safety, and welfare of all Americans,
Recipient must distribute or administer vaccine without discriminating on non -public-health grounds
within a prioritized group. This includes, but is not limited to, immigration status, criminal history,
incarceration, or homelessness. To this end, and to help achieve the public health imperative of widespread
herd immunity to COVID-19, Recipient must administer or distribute vaccine to any and all individuals
within a prioritized group in the same timeframe, taking into account available vaccine doses. For example,
if meatpacking plant workers are a prioritized group, then all workers in that group, including
undocumented immigrants, must be vaccinated to help assure that the plant is in a position to safely
resume essential functions. In addition, to the extent applicable, Recipient will comply with Section 18115
of the CARES Act, with respect to the reporting to the HHS Secretary of results of tests intended to detect
SARS-CoV-2 or to diagnose a possible case of COVID-19. Such reporting shall be in accordance with
guidance and direction from HHS and/or CDC. HHS laboratory reporting guidance is posted at:
https://www hhs.gov/sites/default/files/covid-19-laboratory-data-reporting-guidance pdf.
• Further, consistent with the full scope of applicable grant regulations (45 C.F.R. 75.322), the purpose of this
award, and the underlying funding, the recipient is expected to provide to CDC copies of and/or access to
COVID-19 data collected with these funds, including but not limited to data related to COVID-19 testing.
CDC will specify in further guidance and directives what is encompassed by this requirement.
• This award is contingent upon agreement by the recipient to comply with existing and future guidance
from the HHS Secretary regarding control of the spread of COVID-19. In addition, recipient is expected to
flow down these terms to any subaward, to the extent applicable to activities set out in such subaward.
Unallowable Costs:
• Resources or activities funded by another HSS Contract, grant, or MOA
• Purchase of vehicles
• Reimbursement of pre -award costs
• Research
• Indirect costs associated with the award
• Food and/or water
• Hospital bill or insurance claims
• Clinical care
• Publicity and propaganda (lobbying):
• Other than for normal and recognized executive -legislative relationships, no funds may be used for:
o publicity or propaganda purposes, for the preparation, distribution, or use of any material designed
to support or defeat the enactment of legislation before any legislative body
o the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related
to any activity designed to influence the enactment of legislation, appropriations, regulation,
administrative action, or Executive order proposed or pending before any legislative body
o See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional
guidance on lobbying for CDC recipients: https://www.cdc.gov/grants/documents/Anti-
Lobbying_Restrictions-for-CDCGranteesjuly-2012.pdf
o All unallowable costs cited in CDC-RFA-TP18-1802 remain in effect, unless specifically amended in
this guidance, in accordance with 45 CFR Part 75 - Uniform Administrative Requirements, Cost
Principles, and Audit Requirements for HHS Awards.
Vlll. CONTACT INFORMATION
DPH-EOC primary point of contact: Maria Caruso
Division of Public Health, COVID Program Coordinator
3601 C Street, Suite 722
Anchorage AK 99503
Office: 907-310-6092
Email: maria.carusoCa alaska.eov
KIB primary point of contact: Meagan Christiansen
KIB, Grant Writer/Special Projects Support
Office: 907-406-9303
Email: mchristiansenAkodiakak.us
KIB finance contact: Dora Cross
KIB, Finance Director
Office: 907-486-9323
Email: dcross(o)kodiakak.us
KIB additional contact: Michael Powers
KIB, Borough Manager
Office: 907-486-9320
Email: mpowersCa0kodiakak us
SIGNATURES
By signature of the below, both parties agree to the terms of this MOA.
Kodiak Island Boroueh (/( I_
By: Date:4�
Michael Poweris, Borough Manager, Kodiak Island oroug (i
State of Alaska
By: Date: 4/27/2021
aria Caruso, -EOC Program Coordinator
By: _ - Date:
05/04/2021
Heidi Hedberg, EOC/Unified Commander & DPH Director
By: �"'�' 0 {— Date: 4/29/2021
Jason G ve, Procurement Manager
By: Date: L i 517-1
Iv n Robb, DHSS Assistant Commissioner
O�
AASKN�151